Mar 04, 2019
Neovasc's Tiara(TM) Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting
Feb 28, 2019
Neovasc announces closing of $5 million public offering of common shares
Feb 27, 2019
Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
Feb 26, 2019
Neovasc Announces Pricing of $5 Million Public Offering of Common Shares
Feb 25, 2019
Neovasc Announces Proposed Public Offering of Common Shares
Feb 22, 2019
Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018
Feb 21, 2019
Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World
Feb 20, 2019
Micro Interventional Devices, Inc. Reaches Settlement Agreement with Neovasc, Inc.
Feb 20, 2019
Neovasc Provides Corporate Update
Feb 11, 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
Jan 30, 2019
Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Jan 29, 2019
Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK
Jan 23, 2019
Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation
Jan 22, 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Jan 14, 2019
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Jan 03, 2019
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Dec 21, 2018
Neovasc Receives ISO 13485: 2016 Certification
Dec 11, 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Nov 20, 2018
JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer(TM) Patient Case
Nov 14, 2018
Neovasc Announces Third Quarter 2018 Financial Results